Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects. - Wikidata - awgldk - TriplyDB

Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.

Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.

http://www.wikidata.org/entity/Q36306690

about

Familial apolipoprotein E deficiency The involvement of Reelin in neurodevelopmental disorders.Role of apolipoprotein E in neurodegenerative diseases Structure of the Minimal Interface Between ApoE and LRP Genetic studies of human apolipoproteins. X. The effect of the apolipoprotein E polymorphism on quantitative levels of lipoproteins in Nigerian blacks Amino acid sequence of human plasma apolipoprotein C-III from normolipidemic subjects Biophysical analysis of apolipoprotein E3 variants linked with development of type III hyperlipoproteinemia Decoding of lipoprotein-receptor interactions: properties of ligand binding modules governing interactions with apolipoprotein E.Apolipoprotein-E forms dimers in human frontal cortex and hippocampus Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic.Genetic basis of lipoprotein disorders.A non-invasive, rapid method to genotype late-onset Alzheimer's disease-related apolipoprotein E gene polymorphisms Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree Profile of Robert W. Mahley.Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in patients with familial dysbetalipoproteinemia.Pre-beta-very low density lipoproteins as precursors of beta-very low density lipoproteins. A model for the pathogenesis of familial dysbetalipoproteinemia (type III hyperlipoproteinemia)Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia)Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects.A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1 New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.Trans-ethnic fine-mapping of lipid loci identifies population-specific signals and allelic heterogeneity that increases the trait variance explained.Apolipoproteins in the brain: implications for neurological and psychiatric disorders.Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: no cosegregation with severe hyperlipidemia.Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation.Regulation of hepatic lipoprotein receptors in the dog. Rapid regulation of apolipoprotein B,E receptors, but not of apolipoprotein E receptors, by intestinal lipoproteins and bile acids.Identical structural and receptor binding defects in apolipoprotein E2 in hypo-, normo-, and hypercholesterolemic dysbetalipoproteinemia Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia LDL-apheresis depletes apoE-HDL and pre-β1-HDL in familial hypercholesterolemia: relevance to atheroprotection.Apolipoprotein E (APOE) Polymorphisms and Susceptibility to Breast Cancer: A Meta-Analysis.Genetic factors for choroidal neovascularization associated with high myopia.Polymorphism of Apo lipoprotein E gene and the risk of multiple sclerosis.Nucleotide sequence and structure of the human apolipoprotein E gene.The impact of low-frequency and rare variants on lipid levels.The isolation of cDNA clones for human apolipoprotein E and the detection of apoE RNA in hepatic and extra-hepatic tissues.Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.Disulfide bonds and the translocation of proteins across membranes.

P2860

Q24299817-8703746C-3EA1-4DE3-BF80-11D3482E3B1D Q24632484-23CB83C7-7303-4AD8-859B-8B58133C8021 Q26799413-A64F4DA9-6304-4324-8C30-8FF5321C1574 Q27660292-9EE6A25F-CF8E-4BF3-A45E-78EEBC2CB69A Q28241638-030FA508-9E58-4858-93C2-CAE522139BB5 Q28307638-A7BA404B-2DCB-4904-95FA-9A9D59A704F7 Q28477741-D6D66A4E-952D-4E81-91DE-66E8D52C7D14 Q30433192-D41550A7-0C3A-41BB-9A6A-9B7C9064FCD0 Q33532794-1C933F1F-6379-4318-82B3-CB5372A0728D Q33821952-D1FDD0ED-C314-4C98-A10A-04FC9A698F4E Q33822165-AA26E933-AA03-424C-99C8-BB592800E1C6 Q33847743-45960D08-989B-4A2D-957C-B5D773198372 Q34096343-920B8048-F457-4D7B-824F-CC39936A8A37 Q34185850-300B2D94-824D-4DA3-B5C8-F0B7D8759655 Q34194380-EF1B9C6F-ECD8-45BE-81A8-7162E5C56239 Q34508773-0E992A02-DC6C-4576-ACA0-A9EBCB437395 Q34538275-C752381A-C7C4-4D8E-BE3D-FB41BD678C21 Q34560246-B00E5B91-3FF5-45AC-B8DE-AACFF0E97A2D Q34569772-4D341D0C-0889-4848-8ADC-5CBFFB3F7B5E Q34581286-7F3C40D8-72D9-4A8D-8058-53A1716D8C51 Q34606014-485B73A2-478B-4038-B553-7A718155AAD3 Q34607518-AADB1E0A-DF23-46ED-98B6-218138569B95 Q34616680-B96DCA2C-BF90-4FB9-B353-66BF9406BA2E Q34649888-E122C0A6-8AE9-4551-A568-21F1D0E991BE Q34680878-61B3F127-2242-47CA-BEC1-2D24EC6CA6DB Q35194099-39E53A36-2CB1-4322-9BC4-557A13C734A7 Q35200206-369FB7FD-9A80-4373-949A-CDC6AD92A4AF Q35205251-F289A995-72EB-4879-B2FD-0E851923E1C4 Q35205937-401499F0-633E-4320-8867-823612DB3350 Q35577335-27E9CB08-4C14-4544-A98F-8294D1369324 Q35768586-3DA0D145-4C27-4FFA-8633-3A2F2B7D4C11 Q36089560-6032D486-03C5-4D0A-B7B9-2D6E7D83028E Q36136294-2E17678A-4C0A-4388-8289-367048EEAE7D Q36212078-5AA33ED2-20D0-4DC1-A631-91412A216C34 Q36423417-A577FD82-DCCF-483F-887C-A8EF3DC2AF54 Q36591109-918DF501-907B-4F61-9AD3-DFF0FED74F83 Q36592147-D575E81D-D4A3-4C83-98C8-B25DE4397CC9 Q36991404-CB2812BD-BB28-41C5-B87F-97A507A532FB Q37380855-F0D67644-E9A7-456D-8619-91CAF5AD9F34 Q37409129-197BD6F5-D8D2-4A69-ABE5-164D107C1517

P2860

Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.

http://www.wikidata.org/entity/Q36306690

description

1982 nî lūn-bûn

@nan

1982年の論文

@ja

1982年学术文章

@wuu

1982年学术文章

@zh-cn

1982年学术文章

@zh-hans

1982年学术文章

@zh-my

1982年学术文章

@zh-sg

1982年學術文章

@yue

1982年學術文章

@zh

1982年學術文章

@zh-hant

name

Structural basis for receptor ...... hyperlipoproteinemic subjects.

@ast

Structural basis for receptor ...... hyperlipoproteinemic subjects.

@en

type

label

Structural basis for receptor ...... hyperlipoproteinemic subjects.

@ast

Structural basis for receptor ...... hyperlipoproteinemic subjects.

@en

prefLabel

Structural basis for receptor ...... hyperlipoproteinemic subjects.

@ast

Structural basis for receptor ...... hyperlipoproteinemic subjects.

@en

P1433

Q36306690-F551158E-DAE1-4725-AFDD-BDE3F96090B1

P1476

Q36306690-FABC37E7-445B-412F-940B-B3397D8E46F3

P2093

Q36306690-1C26DA6E-BD92-4340-9189-6728A62F7FB8

Q36306690-20ED610A-04B6-4A9B-B5B8-97DE76E84F9C

Q36306690-263E27AA-9839-49DA-8895-BEA8A13AFEAE

Q36306690-927D76A4-A9A1-49FA-A513-3FE0AD5C159B

P2860

Q36306690-049CDFAB-50A5-48E4-8F29-333CD4FF42D2

Q36306690-14D68C1D-DED3-4035-801F-BBE3AD4D269F

Q36306690-54E2201D-577B-4E20-B94F-BED0134D32A0

Q36306690-5DBB30A7-10BE-4E8F-97E6-2FD189359E82

Q36306690-BDEA853E-DA12-4665-BB61-F45E9D4D02FA

Q36306690-C1C68ED5-DC75-4317-AB12-5D240E842DB0

Q36306690-D0CE4869-3B34-4090-9ED6-55AA7F61BEAC

Q36306690-E7B58CCC-B5CB-4CDF-8F37-7DAAAF36E547

Q36306690-FA379503-7A45-4991-BF31-57577779944B

Q36306690-FF1C398D-FBDD-4F0D-A50F-02B34EBA5B4F

P304

Q36306690-E3B46A64-6F20-4E1B-A327-48BA1E3F8845

P31

Q36306690-4536DE22-25BC-40C6-A335-EA87E6B13143

P356

Q36306690-D926035D-6951-4AAD-8CC2-831987796736

P407

Q36306690-C6592734-AA2A-4834-8751-B113E5039125

P433

Q36306690-473F0DA0-8DE1-44E1-AAA6-81B8D869DDA9

P478

Q36306690-424D03BC-4B5F-40D7-B14E-3A96E07FE097

P577

Q36306690-BD4DA668-ABA5-46F2-96D9-FD1A29737624

P5875

Q36306690-4B9C1095-D99C-4F31-A487-63A51B174AD5

P698

Q36306690-7588D86A-7452-41C8-8E9E-EF605CD0EEDC

P932

Q36306690-AF1B18EC-6CF1-45D5-AC0E-94B01927FD27

P356

PNAS.79.15.4696

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Structural basis for receptor ...... hyperlipoproteinemic subjects.

@en

P2093

Innerarity TL

http://www.w3.org/2001/XMLSchema#string

Mahley RW

http://www.w3.org/2001/XMLSchema#string

Rall SC Jr

http://www.w3.org/2001/XMLSchema#string

Weisgraber KH

http://www.w3.org/2001/XMLSchema#string

P2860

Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site

Human apolipoprotein E isoprotein subclasses are genetically determined.

Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia.

Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.

Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptors.

Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins.

Characterization of human very low density lipoproteins containing two electrophoretic populations: double pre-beta lipoproteinemia and primary dysbetalipoproteinemia.

Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins.

Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III.

Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts.

P304

4696-4700

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.79.15.4696

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P577

1982-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

16907595

http://www.w3.org/2001/XMLSchema#string

P698

6289314

http://www.w3.org/2001/XMLSchema#string

P932

346743

http://www.w3.org/2001/XMLSchema#string